Latest

Latest multiple sclerosis News | Page 6

  • Latest multiple sclerosis news stories and updates. What is happening today? All recent multiple sclerosis news and developments. Live coverage and timeline of multiple sclerosis. All you need to know about multiple sclerosis.
Academic-industry partnership aims to lower cost of cultivated meat
Four Curtin researchers recognised in 2022 WA Young Tall Poppy Awards
NeuroScientific Biopharmaceuticals reports positive data from animal study
New Changing Place supporting Fremantle locals and visitors with disability
Government response to independent Pharmac Review
NeuroScientific Biopharmaceuticals submits for approval of early-phase trial
Ultomiris met primary endpoint in CHAMPION-NMOSD Phase III trial
How Herpesviruses Awaken
Hitting nerve: how antidepressants treat nerve pain
Findings open way for personalised MS treatment
Australia’s Post-viral Disease Tsunami Threat
Could releasing ‘handbrake’ immune cells help supercharge immunity?
Artificial Intelligence research project winner in $2.1 million funding program
University of Sydney rises in QS subject rankings
Nine out of 10 Aussies have low vitamin D intakes, Curtin study shows
AstraZeneca’s antibody combination, Evusheld▼ authorised for use
Discovery may help reduce side effects of MS drugs
From driveways to mRNA, startup founders bolster University of Toronto’s rapid rise in entrepreneurship space
Survivors of code red condition offer hope as half of those with Covid experience signs similar to brain injury
Researchers use diet to fight multiple sclerosis
Medicinal cannabis in sport: An insight for athletes and support people
Funding support to discover ways to block migration of T-cells responsible for MS
‘Boot camp’ enzyme prevents autoimmune conditions
New genetic clues on multiple sclerosis risk
Meat eating linked to inflammation, worse gut health and MS
Weapon in immune system arsenal could unlock MS treatment
QIMR Berghofer attracts support for potential multiple sclerosis treatment
Evusheld long-acting antibody combination authorised for emergency use
Immune cells may trigger inflammation in MS
QIMR Berghofer signs licensing, research and manufacturing deal for new cellular immunotherapy with US company Cellevolve Bio
Victorian Premier issues statement 24 November
New analyses of two AZD7442 Covid Phase III trials in high-risk populations confirm robust efficacy and long-term prevention
Australians with MS sought to ‘taste test’ new nutrition program
Cannabis use disorder during pregnancy on rise
Potential new strategy to combat urinary tract infections
Tiny bubbles can be future treatment for inflammation
Campaign could reduce risk of UK opioid ‘epidemic’
Conversation with Paralympians
Landmark PBS Listings to reduce cost of medicines for Australians
New research shows drug repurposing is no ‘quick-fix’ in race to treat Covid
Prestigious grants success for Centenary Institute researchers
Fire Preparedness with people who have a disability, a chance to listen
Physio, chiro, osteo and myo: whats difference and which one should I get?
Altered ‘coat’ disguises fatal brain virus from neutralizing antibodies
Future of MS health care – new digital tool receives vital funding
Canberra United powerchair team receives new wheels
New Robot-Assisted Therapy Launches in Australia on World Stroke Day
New medicines for Australians with multiple sclerosis, lymphoma, carcinoma and reproductive cancers

© 2026 - The National Tribune Australia